Levine James E. 4
4 · Cidara Therapeutics, Inc. · Filed Nov 12, 2020
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-11-10$2.01/sh+50,000$100,720→ 50,000 total(indirect: By Spouse)
Holdings
- 65,834
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.97 to $2.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]Includes 3,943 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2020.